Guanze Medical Information Industry (Holding) Co., Ltd. (Guanze Medical) filed its monthly return for the period ended 31 October 2026, confirming that both its authorised and issued share capital remained unchanged during the month.
Authorised Capital • Authorised share count held steady at 10.00 billion ordinary shares with a par value of HKD 0.01, equal to HKD 100.00 million in authorised capital.
Issued Shares • Outstanding shares: 950.00 million. • Treasury shares: none. • No share issuances, cancellations, conversions, redemptions, or share option exercises were recorded.
Public Float • Guanze Medical confirmed compliance with the Main Board’s minimum public float requirement of 25% as at 31 October 2026.
Capital Instruments • The company reported no outstanding or newly issued share options, warrants, convertible securities, Hong Kong Depositary Receipts, or other agreements that could dilute existing shareholders.
Filing Details • Submission date: 06 November 2026. • The filing was signed by Company Secretary Cheng Cheung King.
Comments